Eli Lilly looks to extend its winning streak over the broader market to 6 years
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Why Americans are outraged over health insurance — and what could change
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Health AI startup Suki expands partnership with Google Cloud to deliver more assistive tech for clinicians
